Evidence map›Paper›PMID 14689578›Full record

ReviewJournal of cellular biochemistry2004

Integrin clipping: a novel adhesion switch?

Manolis C Demetriou, Anne E Cress

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of cellular biochemistry, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Caudamins, a new subclass of protein hormones.Trends in endocrinology and metabolism: TEM · 2021
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effects of down-regulation of integrin-beta1 expression on migration and hepatic metastasis of human colon carcinoma.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2010
    Article
  18. Review
  19. Article
  20. Prostate cancer regulatory networks.Journal of cellular biochemistry · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Manolis C DemetriouDepartment of Cell Biology and Anatomy, The Arizona Cancer Center, Tucson, Arizona 85724, USA.
Anne E Cress
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
ROLE OF METALLOPROTEINASES AND TIMP IN HUMAN PROSTATE CELL INVASIONP01CA056666 · NCI · UNIVERSITY OF ARIZONA · PI HEIMARK, RONALD L. · 1993 to 2008
$6.3M
RADIATION SIGNALING THROUGH THE ALPHA6 BETA4 INTEGRINR01CA075152 · NCI · UNIVERSITY OF ARIZONA · PI CRESS, ANNE ELIZABETH · 1998 to 2005
$1.5M
NCI NIH HHS P01 CA056666NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA075152
6 · The paper itself

Abstract

During human prostate cancer progression, the majority of normally expressed integrins are suppressed with the exception of the alpha6, alpha3, and beta1 integrins. We have shown that in prostate cancer, the alpha6 integrin is found paired with the beta1 integrin and that a novel form of the alpha6 integrin that lacks a large portion of the extracellular domain (alpha6p) exists. The alpha6pbeta1 integrin is found in human prostate cancer tissue specimens as well as tissue culture cell lines and is formed on the cell surface. This review discusses the mechanism of alpha6pbeta1 production and the potential functions of this integrin variant. Our current working model predicts that the alpha6pbeta1 integrin maintains the intracellular cytoskeletal connections associated with the heterodimer while allowing for an alteration in cell adhesion. The mechanism provides a selective advantage for cancer cell metastasis.

Indexed as

Cell AdhesionHumansIntegrin alpha3Integrin alpha6Integrin beta1MaleProstatic NeoplasmsProtein IsoformsUrokinase-Type Plasminogen ActivatorIntegrin alpha3Integrin alpha6Integrin beta1Protein IsoformsUrokinase-Type Plasminogen Activator

Identifiers

PMID14689578
PMCPMC2702438
OpenAlexW2153079197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.